(-)-demecolcine increases expression ISO RGD:1345136 6480464 Demecolcine results in increased expression of TBC1D4 mRNA CTD PMID:23649840 (S)-colchicine multiple interactions ISO RGD:1561609 6480464 Colchicine inhibits the reaction [Oligomycins results in increased phosphorylation of TBC1D4 protein] CTD PMID:18063688 (S)-colchicine affects phosphorylation ISO RGD:1561609 6480464 Colchicine affects the phosphorylation of TBC1D4 protein CTD PMID:18063688 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of TBC1D4 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of TBC1D4 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:1345136 6480464 Dinitrochlorobenzene binds to TBC1D4 protein CTD PMID:32991956 17beta-estradiol decreases expression ISO RGD:1561609 6480464 Estradiol results in decreased expression of TBC1D4 mRNA CTD PMID:32145629 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1345136 6480464 Dihydrotestosterone results in increased expression of TBC1D4 mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1561609 6480464 Tetrachlorodibenzodioxin affects the expression of TBC1D4 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1561609 6480464 Tetrachlorodibenzodioxin results in decreased expression of TBC1D4 mRNA CTD PMID:33387578 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of TBC1D4 mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of TBC1D4 mRNA CTD PMID:26251327 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of TBC1D4 mRNA CTD PMID:28973697 5-azacytidine decreases expression ISO RGD:1345136 6480464 Azacitidine results in decreased expression of TBC1D4 mRNA CTD PMID:19194470 6-propyl-2-thiouracil decreases expression ISO RGD:1561609 6480464 Propylthiouracil results in decreased expression of TBC1D4 mRNA CTD PMID:24780913 9-cis-retinoic acid multiple interactions ISO RGD:1561609 6480464 Oligomycins promotes the reaction [Alitretinoin results in increased phosphorylation of TBC1D4 protein] CTD PMID:18063688 9-cis-retinoic acid increases phosphorylation ISO RGD:1561609 6480464 Alitretinoin results in increased phosphorylation of TBC1D4 protein CTD PMID:18063688 aflatoxin B1 increases methylation ISO RGD:1345136 6480464 Aflatoxin B1 results in increased methylation of TBC1D4 exon, Aflatoxin B1 results in increased methylation of TBC1D4 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:1561609 6480464 Aflatoxin B1 results in decreased expression of TBC1D4 mRNA CTD PMID:33354967 Aflatoxin B2 alpha increases methylation ISO RGD:1345136 6480464 aflatoxin B2 results in increased methylation of TBC1D4 exon CTD PMID:30157460 AICA ribonucleotide multiple interactions EXP 6480464 AICA ribonucleotide inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein] CTD PMID:24343960 , PMID:26627467 aldehydo-D-glucose multiple interactions ISO RGD:1345136 6480464 GH1 protein promotes the reaction [Glucose results in increased phosphorylation of TBC1D4 protein] CTD PMID:21559284 aldehydo-D-glucose increases phosphorylation ISO RGD:1345136 6480464 Glucose results in increased phosphorylation of TBC1D4 protein CTD PMID:21559284 all-trans-retinoic acid decreases expression ISO RGD:1345136 6480464 Tretinoin results in decreased expression of TBC1D4 mRNA CTD PMID:23724009 , PMID:33167477 aristolochic acid A decreases expression ISO RGD:1345136 6480464 aristolochic acid I results in decreased expression of TBC1D4 mRNA CTD PMID:33212167 arotinoid acid increases phosphorylation ISO RGD:1561609 6480464 4-(2-(5 more ... CTD PMID:18063688 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with Dietary Fats] affects the phosphorylation of TBC1D4 protein CTD PMID:24726979 benzo[a]pyrene affects methylation ISO RGD:1345136 6480464 Benzo(a)pyrene affects the methylation of TBC1D4 exon CTD PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1345136 6480464 7 more ... CTD PMID:19150397 Benzo[ghi]perylene increases expression EXP 6480464 1, 12-benzoperylene results in increased expression of TBC1D4 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1561609 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TBC1D4 protein], Diethylhexyl Phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein] CTD PMID:21911000 , PMID:28526321 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1561609 6480464 Diethylhexyl Phthalate results in increased expression of TBC1D4 protein CTD PMID:21911000 bisphenol A multiple interactions ISO RGD:1561609 6480464 bisphenol A results in decreased expression of and results in decreased phosphorylation of TBC1D4 protein CTD PMID:28739533 bisphenol A decreases methylation ISO RGD:1345136 6480464 bisphenol A results in decreased methylation of TBC1D4 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TBC1D4 mRNA CTD PMID:35598803 bisphenol A affects expression ISO RGD:1561609 6480464 bisphenol A affects the expression of TBC1D4 mRNA CTD PMID:32145629 caffeine affects phosphorylation ISO RGD:1345136 6480464 Caffeine affects the phosphorylation of TBC1D4 protein CTD PMID:35688186 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of TBC1D4 mRNA CTD PMID:25554681 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of TBC1D4 mRNA CTD PMID:37019170 ciglitazone multiple interactions ISO RGD:1345136 6480464 [ciglitazone binds to PPARG protein] which results in increased expression of TBC1D4 mRNA CTD PMID:16197558 ciglitazone increases phosphorylation ISO RGD:1561609 6480464 ciglitazone results in increased phosphorylation of TBC1D4 protein CTD PMID:18063688 cisplatin multiple interactions ISO RGD:1345136 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of TBC1D4 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:1345136 6480464 cobaltous chloride results in decreased expression of TBC1D4 mRNA CTD PMID:19320972 copper atom multiple interactions ISO RGD:1345136 6480464 [NSC 689534 binds to Copper] which results in decreased expression of TBC1D4 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1345136 6480464 [NSC 689534 binds to Copper] which results in decreased expression of TBC1D4 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1345136 6480464 Copper Sulfate results in decreased expression of TBC1D4 mRNA CTD PMID:19549813 coumarin affects phosphorylation ISO RGD:1345136 6480464 coumarin affects the phosphorylation of TBC1D4 protein CTD PMID:35688186 Cuprizon decreases expression ISO RGD:1561609 6480464 Cuprizone results in decreased expression of TBC1D4 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:1345136 6480464 Cyclosporine results in decreased expression of TBC1D4 mRNA CTD PMID:25562108 cytarabine decreases expression ISO RGD:1345136 6480464 Cytarabine results in decreased expression of TBC1D4 mRNA CTD PMID:21198554 D-glucose multiple interactions ISO RGD:1345136 6480464 GH1 protein promotes the reaction [Glucose results in increased phosphorylation of TBC1D4 protein] CTD PMID:21559284 D-glucose increases phosphorylation ISO RGD:1345136 6480464 Glucose results in increased phosphorylation of TBC1D4 protein CTD PMID:21559284 DDT decreases methylation ISO RGD:1561609 6480464 DDT results in decreased methylation of TBC1D4 gene CTD PMID:31682807 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TBC1D4 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1345136 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TBC1D4 mRNA CTD PMID:27188386 dorsomorphin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Quercetin inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein]] CTD PMID:24343960 endosulfan increases expression ISO RGD:1561609 6480464 Endosulfan results in increased expression of TBC1D4 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO RGD:1345136 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TBC1D4 protein CTD PMID:23301498 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of TBC1D4 mRNA CTD PMID:35436446 fenvalerate increases expression ISO RGD:1561609 6480464 fenvalerate results in increased expression of TBC1D4 mRNA CTD PMID:30307764 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of TBC1D4 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1345136 6480464 Formaldehyde results in increased expression of TBC1D4 mRNA CTD PMID:23649840 gentamycin decreases expression ISO RGD:1561609 6480464 Gentamicins results in decreased expression of TBC1D4 mRNA CTD PMID:33387578 ginsenoside Re increases phosphorylation EXP 6480464 ginsenoside Re results in increased phosphorylation of TBC1D4 protein CTD PMID:17885204 glucose multiple interactions ISO RGD:1345136 6480464 GH1 protein promotes the reaction [Glucose results in increased phosphorylation of TBC1D4 protein] CTD PMID:21559284 glucose increases phosphorylation ISO RGD:1345136 6480464 Glucose results in increased phosphorylation of TBC1D4 protein CTD PMID:21559284 hexadecanoic acid increases phosphorylation ISO RGD:1345136 6480464 Palmitic Acid results in increased phosphorylation of TBC1D4 protein CTD PMID:28073184 hexadecanoic acid multiple interactions ISO RGD:1561609 6480464 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of TBC1D4 protein]], Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of TBC1D4 protein] CTD PMID:25109277 hydrogen peroxide affects expression ISO RGD:1345136 6480464 Hydrogen Peroxide affects the expression of TBC1D4 mRNA CTD PMID:20044591 hydrogen peroxide multiple interactions EXP 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 L-ascorbic acid multiple interactions ISO RGD:1561609 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TBC1D4 protein] CTD PMID:21911000 lipopolysaccharide multiple interactions ISO RGD:1345136 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TBC1D4 mRNA CTD PMID:35811015 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [[Dietary Sugars co-treated with Dietary Fats co-treated with Streptozocin] results in decreased phosphorylation of TBC1D4 protein] CTD PMID:31743741 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of TBC1D4 mRNA CTD PMID:26307267 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1561609 6480464 [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of TBC1D4 protein, mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein] CTD PMID:28526321 paracetamol increases expression ISO RGD:1561609 6480464 Acetaminophen results in increased expression of TBC1D4 mRNA CTD PMID:33387578 PCB138 multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of TBC1D4 mRNA CTD PMID:18301758 quercetin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Quercetin inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein]], Quercetin inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein] CTD PMID:24343960 , PMID:26627467 quercetin increases phosphorylation EXP 6480464 Quercetin results in increased phosphorylation of TBC1D4 protein CTD PMID:24343960 , PMID:26627467 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1345136 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TBC1D4 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1345136 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TBC1D4 mRNA CTD PMID:27188386 streptozocin multiple interactions EXP 6480464 [Dietary Sugars co-treated with Dietary Fats co-treated with Streptozocin] results in decreased expression of and results in decreased phosphorylation of TBC1D4 protein more ... CTD PMID:31743741 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TBC1D4 mRNA CTD PMID:21641980 sunitinib increases expression ISO RGD:1345136 6480464 Sunitinib results in increased expression of TBC1D4 mRNA CTD PMID:31533062 temozolomide decreases expression ISO RGD:1345136 6480464 Temozolomide results in decreased expression of TBC1D4 mRNA CTD PMID:31758290 testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of TBC1D4 mRNA CTD PMID:20403060 topotecan affects response to substance ISO RGD:1345136 6480464 TBC1D4 protein affects the susceptibility to Topotecan CTD PMID:16217747 trichostatin A increases expression ISO RGD:1345136 6480464 trichostatin A results in increased expression of TBC1D4 mRNA CTD PMID:24935251 triptonide decreases expression EXP 6480464 triptonide results in decreased expression of TBC1D4 mRNA CTD PMID:33045310 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of TBC1D4 mRNA CTD PMID:28973697 valproic acid affects expression ISO RGD:1345136 6480464 Valproic Acid affects the expression of TBC1D4 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1345136 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TBC1D4 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1345136 6480464 Valproic Acid results in increased expression of TBC1D4 mRNA CTD PMID:23179753 more ... vincaleukoblastine affects response to substance ISO RGD:1345136 6480464 TBC1D4 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vincristine increases expression ISO RGD:1345136 6480464 Vincristine results in increased expression of TBC1D4 mRNA CTD PMID:23649840 vitamin E multiple interactions ISO RGD:1561609 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TBC1D4 protein] CTD PMID:21911000 zoledronic acid decreases expression ISO RGD:1345136 6480464 zoledronic acid results in decreased expression of TBC1D4 mRNA CTD PMID:24714768
